Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-06

Clinical Trial Update: Viral Specific T-Lymphocytes to Treat Adenovirus or CMV [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating Viral Specific T-Lymphocytes for Adenovirus infection and Cytomegalovirus infection; the study is currently active but not r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Viral-specific T-lymphocytes

Snippet

Sponsor: Jessie L. Alexander | Conditions: Adenovirus, Cytomegalovirus Infections | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING